IDYA IDEAYA Biosciences Stock Forecast Outlook:Negative Period (n+30) 27 Dec 2020


Stock Forecast


As of Thu Dec 24 2020 21:00:02 GMT+0000 (Coordinated Universal Time) shares of IDYA IDEAYA Biosciences -1.68 percentage change in price since the previous day's close. Around 56129 of 29070000 changed hand on the market. The Stock opened at 13.23 with high and low of 12.8 and 13.29 respectively. The price/earnings ratio is: - and earning per share is -1.89. The stock quoted a 52 week high and low of 2.95 and 19.97 respectively.

BOSTON (AI Forecast Terminal) Sun, Dec 27, '20 AI Forecast today took the forecast actions: In the context of stock price realization of IDYA IDEAYA Biosciences is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for IDYA IDEAYA Biosciences as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of IDYA IDEAYA Biosciences as below:

IDYA IDEAYA Biosciences Credit Rating Overview


We rerate IDYA IDEAYA Biosciences bacause the bail-in of that type of liability would not provide any economic benefit to the resolution or would even destroy value. We use econometric methods for period (n+30) simulate with OCL Independent T-Test. Reference code is: 4190. Beta DRL value REG 29 Rational Demand Factor LD 5112.219. When determining the cash to be included under sources (A), we use cash that will be available to cover monetary outflows. As a result, we may make haircuts to account for cash trapped overseas (for example, haircut for taxes payable upon repatriation of cash held abroad), apply a discount to lower-quality marketable securities, and exclude restricted cash held for specific purposes. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for IDYA IDEAYA Biosciences as below:
Frequently Asked QuestionsQ: What is IDYA IDEAYA Biosciences stock symbol?
A: IDYA IDEAYA Biosciences stock referred as NASDAQ:IDYA
Q: What is IDYA IDEAYA Biosciences stock price?
A: On share of IDYA IDEAYA Biosciences stock can currently be purchased for approximately 12.9
Q: Do analysts recommend investors buy shares of IDYA IDEAYA Biosciences ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for IDYA IDEAYA Biosciences at daily forecast section
Q: What is the earning per share of IDYA IDEAYA Biosciences ?
A: The earning per share of IDYA IDEAYA Biosciences is -1.89
Q: What is the market capitalization of IDYA IDEAYA Biosciences ?
A: The market capitalization of IDYA IDEAYA Biosciences is 374999400
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com